178 related articles for article (PubMed ID: 30156165)
1. The Role of Heat Shock Proteins in Cisplatin Resistance.
Krawczyk Z; Gogler-Pigłowska A; Sojka DR; Scieglinska D
Anticancer Agents Med Chem; 2018; 18(15):2093-2109. PubMed ID: 30156165
[TBL] [Abstract][Full Text] [Related]
2. Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells.
Hettinga JV; Lemstra W; Meijer C; Los G; de Vries EG; Konings AW; Kampinga HH
Int J Cancer; 1996 Sep; 67(6):800-7. PubMed ID: 8824551
[TBL] [Abstract][Full Text] [Related]
3. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells.
Lin Y; Wang Z; Liu L; Chen L
Lung Cancer; 2011 Mar; 71(3):291-7. PubMed ID: 20599289
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T
Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136
[TBL] [Abstract][Full Text] [Related]
5. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589
[TBL] [Abstract][Full Text] [Related]
6. Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells.
Jiang CC; Mao ZG; Avery-Kiejda KA; Wade M; Hersey P; Zhang XD
Carcinogenesis; 2009 Feb; 30(2):197-204. PubMed ID: 18842681
[TBL] [Abstract][Full Text] [Related]
7. Reduction of cellular cisplatin resistance by hyperthermia--a review.
Hettinga JV; Konings AW; Kampinga HH
Int J Hyperthermia; 1997; 13(5):439-57. PubMed ID: 9354931
[TBL] [Abstract][Full Text] [Related]
8. Geranylgeranylacetone attenuates cisplatin-induced reductions in cell viability by suppressing the elevation of intracellular p53 content without heat shock protein induction.
Hasegawa M; Ishiguro K; Ando T; Goto H
Nagoya J Med Sci; 2012 Feb; 74(1-2):123-31. PubMed ID: 22515118
[TBL] [Abstract][Full Text] [Related]
9. Targeting heat shock proteins in cancer.
Jego G; Hazoumé A; Seigneuric R; Garrido C
Cancer Lett; 2013 May; 332(2):275-85. PubMed ID: 21078542
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay.
Lee JH; Sun D; Cho KJ; Kim MS; Hong MH; Kim IK; Lee JS; Lee JH
J Cancer Res Clin Oncol; 2007 Jan; 133(1):37-46. PubMed ID: 16906418
[TBL] [Abstract][Full Text] [Related]
11. The role of heat shock protein (HSP) in atherosclerosis: Pathophysiology and clinical opportunities.
Lu X; Kakkar V
Curr Med Chem; 2010; 17(10):957-73. PubMed ID: 20156167
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance.
Yamamoto K; Okamoto A; Isonishi S; Ochiai K; Ohtake Y
Cancer Lett; 2001 Jul; 168(2):173-81. PubMed ID: 11403922
[TBL] [Abstract][Full Text] [Related]
13. Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention.
Narayanankutty V; Narayanankutty A; Nair A
Curr Drug Targets; 2019; 20(7):727-737. PubMed ID: 30526455
[TBL] [Abstract][Full Text] [Related]
14. The dimethylthiourea-induced attenuation of cisplatin nephrotoxicity is associated with the augmented induction of heat shock proteins.
Tsuji T; Kato A; Yasuda H; Miyaji T; Luo J; Sakao Y; Ito H; Fujigaki Y; Hishida A
Toxicol Appl Pharmacol; 2009 Jan; 234(2):202-8. PubMed ID: 18992762
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.
Nakagawa H; Ohira M; Hayashi S; Abe S; Saito S; Nagahori N; Monde K; Shinohara Y; Fujitani N; Kondo H; Akiyama S; Nakagawara A; Nishimura S
Cancer Lett; 2008 Nov; 270(2):295-301. PubMed ID: 18573595
[TBL] [Abstract][Full Text] [Related]
16. Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer.
Kunii E; Oguri T; Kasai D; Ozasa H; Uemura T; Takakuwa O; Ohkubo H; Takemura M; Maeno K; Niimi A
Cancer Chemother Pharmacol; 2015 May; 75(5):985-91. PubMed ID: 25772757
[TBL] [Abstract][Full Text] [Related]
17. Heat shock proteins in the physiology and pathophysiology of epidermal keratinocytes.
Scieglinska D; Krawczyk Z; Sojka DR; Gogler-Pigłowska A
Cell Stress Chaperones; 2019 Nov; 24(6):1027-1044. PubMed ID: 31734893
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
19. Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability.
Ali AY; Kim JY; Pelletier JF; Vanderhyden BC; Bachvarov DR; Tsang BK
Mol Carcinog; 2015 Nov; 54(11):1301-14. PubMed ID: 25154814
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
Horibe S; Matsuda A; Tanahashi T; Inoue J; Kawauchi S; Mizuno S; Ueno M; Takahashi K; Maeda Y; Maegouchi T; Murakami Y; Yumoto R; Nagai J; Takano M
Life Sci; 2015 Mar; 124():31-40. PubMed ID: 25625243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
